Literature DB >> 23323801

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012.

M A Leone1, M Brainin2, P Boon3, M Pugliatti4, M Keindl2, C L Bassetti5.   

Abstract

This paper is meant to provide guidance to anyone wishing to write a neurological guideline for diagnosis or treatment, and is directed at the Scientist Panels and task forces of the European Federation of Neurological Societies (EFNS). It substitutes the previous guidance paper from 2004. It contains several new aspects: the guidance is now based on a change of the grading system for evidence and for the resulting recommendations, and has adopted The Grading of Recommendations, Assessment, Development and Evaluation system (GRADE). The process of grading the quality of evidence and strength of recommendations can now be improved and made more transparent. The task forces embarking on the development of a guideline must now make clearer and more transparent choices about outcomes considered most relevant when searching the literature and evaluating their findings. Thus, the outcomes chosen will be more critical, more patient-oriented and easier to translate into simple recommendations. This paper also provides updated practical recommendations for planning a guideline task force within the framework of the EFNS. Finally, this paper hopes to find the approval also by the relevant bodies of our future organization, the European Academy of Neurology.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Mesh:

Year:  2013        PMID: 23323801     DOI: 10.1111/ene.12043

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  19 in total

Review 1.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

Review 2.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

3.  European recommendations on organisation of interventional care in acute stroke (EROICAS).

Authors:  Jens Fiehler; Christophe Cognard; Mauro Gallitelli; Olav Jansen; Adam Kobayashi; Heinrich P Mattle; Keith W Muir; Mikael Mazighi; Karl Schaller; Peter D Schellinger
Journal:  Eur Stroke J       Date:  2016-07-26

4.  Parkinson disease: New guidelines for diagnosis of Parkinson disease.

Authors:  Maria José Martí; Eduardo Tolosa
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

Review 5.  Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.

Authors:  Flavio Nobili; Cristina Festari; Daniele Altomare; Federica Agosta; Stefania Orini; Koen Van Laere; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Zuzana Walker; Marina Boccardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-02       Impact factor: 9.236

Review 6.  Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.

Authors:  Marina Boccardi; Cristina Festari; Daniele Altomare; Federica Gandolfo; Stefania Orini; Flavio Nobili; Giovanni B Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-30       Impact factor: 9.236

Review 7.  Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.

Authors:  János Tajti; Délia Szok; Anett Csáti; László Vécsei
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 8.  Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.

Authors:  Alexander Drzezga; Daniele Altomare; Cristina Festari; Javier Arbizu; Stefania Orini; Karl Herholz; Peter Nestor; Federica Agosta; Femke Bouwman; Flavio Nobili; Zuzana Walker; Giovanni Battista Frisoni; Marina Boccardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-13       Impact factor: 9.236

Review 9.  Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.

Authors:  Federica Agosta; Daniele Altomare; Cristina Festari; Stefania Orini; Federica Gandolfo; Marina Boccardi; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Flavio Nobili; Zuzana Walker; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-01       Impact factor: 9.236

10.  The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.

Authors:  Marina Boccardi; Alessandra Dodich; Emiliano Albanese; Angèle Gayet-Ageron; Cristina Festari; Nicholas J Ashton; Gérard N Bischof; Konstantinos Chiotis; Antoine Leuzy; Emma E Wolters; Martin A Walter; Gil D Rabinovici; Maria Carrillo; Alexander Drzezga; Oskar Hansson; Agneta Nordberg; Rik Ossenkoppele; Victor L Villemagne; Bengt Winblad; Giovanni B Frisoni; Valentina Garibotto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-10       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.